SCHEMBL5755068

SCHEMBL5755068

O=C[CH]COCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
CCNB2 O95067 2/20 0.43
CDK1 P06493 2/20 0.43
CDK4 P11802 2/20 0.43
CCNB1 P14635 2/20 0.43
CCND1 P24385 2/20 0.43
CCNB3 Q8WWL7 2/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
IDO1 P14902 1/20 0.41
AGXT P21549 1/20 0.40
SLC1A1 P43005 1/20 0.40
ALOX5 P09917 1/20 0.40
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA9 Q16790 3/20 0.39
ALDH1A1 P00352 2/20 0.39
TK1 P04183 1/20 0.39
CA7 P43166 2/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4574153 0.87 TSHR (0.67) TSHRIDO1AGXTSLC1A1ALOX5
SCHEMBL30425720 0.83 TSHR (0.61) TSHRCCNB2CDK1CDK4CCNB1
SCHEMBL76044 0.83 TSHR (0.61) TSHRCCNB2CDK1CDK4CCNB1
SCHEMBL22160794 0.81 TSHR (0.58) TSHRCCNB2CDK1CDK4CCNB1
SCHEMBL7266237 0.80 TSHR (0.52) TSHRCCNB2CDK1CDK4CCNB1
SCHEMBL6633910 0.80 TSHR (0.52) TSHRCCNB2CDK1CDK4CCNB1
SCHEMBL6633911 0.80 TSHR (0.52) TSHRCCNB2CDK1CDK4CCNB1
SCHEMBL30929702 0.79 TSHR (0.56) TSHRCCNB2CDK1CDK4CCNB1
SCHEMBL1989382 0.79 TSHR (0.56) TSHRIDO1AGXTSLC1A1ALOX5
SCHEMBL1524098 0.78 TSHR (0.67) TSHRMAOBIDO1AGXTALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1434813-A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors ICOS CONP (US) 2003-08-06 CN claimed
EP-3802489-A2 MASP-2 INHIBITORS AND METHODS OF USE Omeros Corporation (US) 2021-04-14 EP disclosed
EP-1242400-B1 PYRROLIDINE DERIVATIVES AS CYCLIC AMP-SPECIFIC PHOSPHODIESTERASE INHIBITORS ICOS CORP (US) 2006-05-03 EP disclosed